Hinge Health (HNGE) – Investment Analysts’ Weekly Ratings Changes

Hinge Health (NYSE: HNGE) recently received a number of ratings updates from brokerages and research firms:

• 10/26/2026 – Hinge Health had its price target raised by Stifel Nicolaus from $115.00 to $130.00. They now have a “buy” rating on the stock.
• 10/16/2026 – Hinge Health had its price target raised by KeyCorp from $125.00 to $140.00. They now have an “overweight” rating on the stock.
• 10/12/2026 – Hinge Health had its price target raised by Barclays from $100.00 to $110.00. They now have an “overweight” rating on the stock.
• 10/8/2026 – Hinge Health was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 9/30/2026 – Hinge Health had its price target raised by Needham & Company LLC from $97.00 to $115.00. They now have a “buy” rating on the stock.
• 9/29/2026 – Hinge Health is now covered by Bank of America. They set a “buy” rating and a $110.00 price target on the stock.
• 9/22/2026 – Hinge Health was upgraded by Weiss Ratings from “sell (d-)” to “hold (c)”.
• 9/22/2026 – Hinge Health had its price target raised by Robert W. Baird from $85.00 to $90.00. They now have a “neutral” rating on the stock.
• 9/8/2026 – Hinge Health had its price target raised by Stifel Nicolaus from $96.00 to $115.00. They now have a “buy” rating on the stock.

Insiders Place Their Bets

In other Hinge Health news, Chairman Gabriel Mecklenburg sold 200,000 shares of Hinge Health stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $103.13, for a total value of $20,626,000.00. Following the completion of the sale, the chairman directly owned 200,000 shares in the company, valued at approximately $20,626,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President James Pursley sold 33,000 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $94.14, for a total value of $3,106,620.00. Following the completion of the transaction, the president directly owned 666,909 shares in the company, valued at approximately $62,782,813.26. This trade represents a 4.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,024,581 shares of company stock worth $95,632,761 in the last quarter. 18.92% of the stock is currently owned by company insiders.

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.